Search
Travere Therapeutics Inc
TVTXAdd to Watchlist
55.890USD
-1.390-2.43%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.16BMarket Cap
LossP/E TTM
TVTX Income Statement
You can find the annual or quarterly income statement of Travere Therapeutics Inc here for insights into the performance and operational efficiency of Travere Therapeutics Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
How do I read Travere Therapeutics Inc's income statement on TradingKey?
Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.
What is the difference between quarterly and annual income statements?
A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.
What does YOY mean on the income statement page?
YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.
Which income statement metrics matter most when analyzing TVTX stock?
Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.
What was Travere Therapeutics Inc's revenue at year end?
Travere Therapeutics Inc reported 490.73M in revenue for fiscal year 2025, up from 233.18M in the previous year.
How much revenue did Travere Therapeutics Inc report in the most recent quarter?
Travere Therapeutics Inc reported 127.20M in revenue for the most recent quarter, an increase of 55.63% year over year.
What was Travere Therapeutics Inc's net income for the year?
Travere Therapeutics Inc posted -25.55M in net income for fiscal year 2025.
How much net income did Travere Therapeutics Inc post in the last quarter?
Travere Therapeutics Inc reported -37.10M in net income for the latest quarter。
What was Travere Therapeutics Inc's annual operating profit?
Travere Therapeutics Inc's operating income was -62.82M for fiscal year 2025.
How is EPS related to the income statement?
EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.